Form D · Other Health Care

Aggredyne, Inc.

Houston, TX · CIK 0001545103

Offering snapshot reported Apr 5, 2012 · SEC filing

Reported sold
$2.85M
Offering amount: $3M
Investors reported
48
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Mar 22, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 5, 2012Initial$2,850,000No comparison48SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$1 (estimated)
Form D file number
021-176230
1,425,000 shares have been sold at the closing of the First Tranche with a commitment to buy an additional 1,425,000 shares after cerain milestones have been achieved.
Warrants to purchase 18,125 shares of common stock to five individuals.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
David BootheNone
Eric ChanNone
Thomas CarlsonNone
Richard FisherNone
Russell HrubyNone

Source: Form D, filed Apr 5, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert C Hux Director, Executive
Edward R Teitel Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
10530 Rockley Road, Suite 150
Houston, TX, 77099